CoChat

Efficacy, tolerability, and safety of cannabinoids for chemotherapy-induced nausea and vomiting—a systematic review of systematic reviews

Tafelski, S., Häuser, W., Schäfer, M. · 2016 · Der Schmerz

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

Background There is growing public and legislative body support for the medical use of cannabis products, for example, for chemotherapy-induced nausea and vomiting (CINV), in Germany. Methods A comprehensive literature search until November 2015 was conducted in MEDLINE, DARE and Cochrane libraries for systematic reviews of randomized controlled trials (RCTs) comparing herbal or pharmaceutical cannabinoids (CB) versus placebo or conventional antiemetics for CINV. Outcomes were reduction of CINV for efficacy, drop-out rates due to adverse events for tolerability, and serious adverse events for safety. The methodology quality of the systematic reviews was evaluated by the tool assessment of multiple systematic reviews (AMSTAR). Results Six systematic reviews of RCTs included the pharmaceutical CBs dronabinol, levonantradol, and nabilone or whole plant extract (e.g., nabiximol) compared with placebo or conventional antiemetics. There was moderate quality evidence on the efficacy of CBs compared to placebo and conventional antiemetics for CINV. There was moderate quality evidence that pharmaceutical CBs were less tolerated and less safe than placebo and conventional antiemetics in CINV. One RCT examining whole plant extract was included into the systematic reviews. No RCT was found comparing CBs with neurokinine-1 receptor antagonists. Conclusions With safe and effective antiemetics available, CBs cannot be recommended as first- or second-line therapy for CINV. Some guidelines re…

Overview

Integrity signals

Registry

Crossref · 10.1007/s00482-015-0092-3

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 30 references

Research works printed but not linked: 2

  1. Aromataris E (2014) Joanna Briggs Institute Reviewers’ Manual: 2014 edition/Supplement. In:Joanna Briggs Institute
  2. Higgins J, Green S (eds) (2011) Cochrane handbook for systematic reviews of interventions. The Cochrane Collaboration. Wiley-Blackwell, Hoboken

Cited by

See all 71

Metadata

Authors
Tafelski, S., Häuser, W., & Schäfer, M.
Affiliations
  • Charité – Universitätsmedizin Berlin (DE)
  • Klinikum Saarbrücken (DE)
Corresponding author
Tafelski, S.
Venue
Der Schmerz
Published
2016-01-19
Volume
30
Issue
1
Pages
14-24
ISSN
  • 0932-433X (ISSN-L)
  • 1432-2129
OpenAlex
W2277470694
Cited by
71
References
30
Citations by year
2026: 4 · 2025: 2 · 2024: 6 · 2023: 8 · 2022: 8 · 2021: 6 · 2020: 7 · 2019: 9 · 2018: 9 · 2017: 7 · 2016: 5
FWCI
1.98
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Der Schmerz (publishedVersion)
  • PubMed (publishedVersion)
  • mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Nausea and vomiting management
  • Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
Keywords
cannabinoids, chemotherapy-induced nausea and vomiting, dronabinol, levonantradol, nabilone, herbal cannabis, antiemetics, tolerability, drug safety, third-line therapy
MeSH terms
Antineoplastic Agents, Humans, Nausea, Vomiting, Treatment Outcome, Medical Marijuana

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy, tolerability, and safety of cannabinoids for chemotherapy-induced nausea and vomiting—a systematic review of systematic reviews. https://app.cochat.ai/papers/10.1007/s00482-015-0092-3
The paper
Tafelski, S., Häuser, W., & Schäfer, M. (2016). Efficacy, tolerability, and safety of cannabinoids for chemotherapy-induced nausea and vomiting—a systematic review of systematic reviews. Der Schmerz. https://doi.org/10.1007/s00482-015-0092-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.